<DOC>
	<DOCNO>NCT00817076</DOCNO>
	<brief_summary>The purpose study test effectiveness safety desloratadine ( Aerius ) syrup child allergic skin inflammation . Patients take desloratadine syrup day 28 day . Once week , doctor measure patient 's symptom . This measurement call SCORAD . The doctor also rat much relief patient get treatment record side effect .</brief_summary>
	<brief_title>Study Effectiveness Safety Desloratadine ( Aerius ) Syrup Children With Allergic Skin Inflammation ( P03475 )</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Children must &gt; = 6 &lt; 12 year age , either sex race . Children 's parent ( ) legal representative ( ) must demonstrate willingness participate study comply procedure sign informed consent . Children must general good health ; i.e . must free clinically significant disease atopic dermatitis ( AD ) would interfere study evaluation . Children 's parent ( ) legal representative ( ) must understand able adhere dose visit schedule , agree report concomitant medication adverse event Investigator designee . The diagnosis AD perform accord Hanifin Rajka criterion ( Hanifin JM , Rajka G. Diagnostic feature atopic dermatitis . Acta Derm Venereol ( Stockhr ) 92 ( suppl ) : 4470 , 1980 ) : include study , child need manifest least 3 major feature 3 minor feature visit 1 ( day 1 ) . Children must clinically symptomatic AD visit 1 ( day 1 ) . Disease severity estimate use SCORAD Index ( European task force atopic dermatitis . Severity score atopic dermatitis : SCORAD Index . Dermatology 186 : 2331 , 1993 ) , child must SCORAD Index least &gt; = 35 . Children observe designate washout period prohibit medication . Children bronchial asthma require chronic use inhale systemic corticosteroid . Children history hypersensitivity desloratadine , excipients . Children current evidence clinically significant hematopoietic , metabolic , cardiovascular , immunologic , neurologic , hematologic , gastrointestinal , hepatic , renal , psychiatric , cerebrovascular , disorder , judgment Investigator , may interfere study evaluation affect child safety . A known lack response H1antihistamines .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>